Shopping Cart 0
Cart Subtotal
USD 0

Hemostasis - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 8000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 12000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Hemostasis-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Hemostasis-Medical Devices Pipeline Assessment, 2018" provides an overview of Hemostasis currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Hemostasis under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Hemostasis and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Hemostasis under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 13

2 Introduction 14

2.1 Hemostasis Overview 14

3 Products under Development 15

3.1 Hemostasis-Pipeline Products by Stage of Development 15

3.2 Hemostasis-Pipeline Products by Segment 16

3.3 Hemostasis-Pipeline Products by Territory 17

3.4 Hemostasis-Pipeline Products by Regulatory Path 18

3.5 Hemostasis-Pipeline Products by Estimated Approval Date 19

4 Hemostasis-Pipeline Products under Development by Companies 20

4.1 Hemostasis Companies-Pipeline Products by Stage of Development 20

4.2 Hemostasis-Pipeline Products by Stage of Development 22

5 Hemostasis Companies and Product Overview 27

5.1 Alere Inc Company Overview 27

5.2 Analyticon Biotechnologies AG Company Overview 28

5.3 Atomo Diagnostics Pty Limited Company Overview 34

5.4 BioMedica USA LLC (Inactive) Company Overview 35

5.5 Braun Biosystems, Inc. Company Overview 36

5.6 Carclo Diagnostic Solutions Ltd Company Overview 37

5.7 Cascade Metrix LLC Company Overview 38

5.8 Diagnostica Stago Inc Company Overview 39

5.9 Edan Instruments Inc Company Overview 46

5.10 EKF Diagnostics Holdings Plc Company Overview 47

5.11 ELITechGroup Inc Company Overview 48

5.12 Emosis SAS Company Overview 49

5.13 Gen-Probe Inc Company Overview 50

5.14 Grifols SA Company Overview 51

5.15 Grifols USA LLC Company Overview 65

5.16 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 66

5.17 Helena Laboratories Corp Company Overview 67

5.18 HemoSonics, LLC Company Overview 82

5.19 Instrumentation Laboratory Company Overview 89

5.20 Massachusetts General Hospital Company Overview 105

5.21 Nexus Medical, LLC Company Overview 106

5.22 Novametics Inc (Inactive) Company Overview 107

5.23 Pakwa Technologies Company Overview 108

5.24 PortaScience Inc Company Overview 109

5.25 Precision Biologics Inc Company Overview 110

5.26 Radiometer Medical ApS Company Overview 111

5.27 Rappaport Family Institute for Research in the Medical Science Company Overview 113

5.28 rHealth Company Overview 114

5.29 SATT Conectus Alsace SAS Company Overview 115

5.30 Sekisui Diagnostics LLC Company Overview 116

5.31 Siemens Healthcare GmbH Company Overview 120

5.32 SonoMedix, Inc. Company Overview 139

5.33 SQI Diagnostics Inc Company Overview 140

5.34 Stichting Lygature Company Overview 141

5.35 Tarabios Company Overview 143

5.36 Transfusion & Transplantation Technologies (Inactive) Company Overview 144

5.37 Universal Biosensors Inc Company Overview 145

5.38 University of Colorado Company Overview 147

5.39 University of Michigan Company Overview 148

5.40 University of Texas Health Science Center at Houston Company Overview 149

5.41 University of Vermont Company Overview 150

6 Hemostasis- Recent Developments 151

6.1 Jun 28, 2018: Baxter Releases 2017 Corporate Responsibility Report and Reinforces Its Commitment to Enriching Communities Around the World 151

6.2 Jun 18, 2018: IBEX Announces Financial Results for the Third Quarter and the Nine Months Ended April 30, 2018 152

6.3 Jun 18, 2018: Abcam Appoints Peter Allen As Chairman 153

6.4 Jun 14, 2018: EMOSIS Announces an Exclusive Distribution Agreement with 5-Diagnostics and the Start of Commercialization 154

6.5 Jun 13, 2018: SQI Diagnostics Names Eric Zwisler As Board Director 154

6.6 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 155

6.7 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 156

6.8 May 25, 2018: Groundbreaking POC hemostasis diagnostic to be presented at Major European Meetings 157

6.9 May 25, 2018: Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends 157

6.10 May 25, 2018: Siemens appoints new CEO of Siemens Mexico, Central America, and Caribbean 159

6.11 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 159

6.12 May 23, 2018: Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency 162

6.13 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference 162

6.14 May 15, 2018: Proposed nominations of future Siemens Alstom Board of Directors completed 164

6.15 May 10, 2018: SQI Diagnostics Reports Second Quarter 2018 Results 165

6.16 May 09, 2018: Siemens Announces Earnings Release and Financial Results Q2 FY 2018 167

6.17 May 09, 2018: Sysmex Group Formulates New Long-Term Management Goals 169

6.18 May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 171

6.19 May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results 174

6.20 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 175

6.21 May 07, 2018: Instrumentation Laboratory Worldwide Sales Top USD970 M In 2017 176

6.22 May 03, 2018: Siemens Healthineers fully on track to meet the targets 176

6.23 May 03, 2018: Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales 177

6.24 May 02, 2018: Hologic Announces Financial Results for Second Quarter of Fiscal 2018 181

6.25 May 01, 2018: Trinity Biotech announces Results for Q1, 2018 183

6.26 May 01, 2018: Predicting side effects before they happen 184

7 Appendix 282

7.1 Methodology 282

7.2 About GlobalData 285

7.3 Contact Us 285

7.4 Disclaimer 285


List Of Figure

1.2 List of Figures

Figure 1: Hemostasis-Pipeline Products by Stage of Development 16

Figure 2: Hemostasis-Pipeline Products by Segment 17

Figure 3: Hemostasis-Pipeline Products by Territory 18

Figure 4: Hemostasis-Pipeline Products by Regulatory Path 19

Figure 5: Hemostasis-Pipeline Products by Estimated Approval Date 20


List Of Table

1.1 List of Tables

Table 1: Hemostasis-Pipeline Products by Stage of Development 16

Table 2: Hemostasis-Pipeline Products by Segment 17

Table 3: Hemostasis-Pipeline Products by Territory 18

Table 4: Hemostasis-Pipeline Products by Regulatory Path 19

Table 5: Hemostasis-Pipeline Products by Estimated Approval Date 20

Table 6: Hemostasis Companies-Pipeline Products by Stage of Development 21

Table 7: Hemostasis-Pipeline Products by Stage of Development 23

Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Table 9: Afinion PT Test-Capillary Blood-Product Status 28

Table 10: Afinion PT Test-Capillary Blood-Product Description 28

Table 11: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 29

Table 12: Coagulyzer 1-Product Status 29

Table 13: Coagulyzer 1-Product Description 30

Table 14: Coagulyzer 100-Product Status 30

Table 15: Coagulyzer 100-Product Description 31

Table 16: Coagulyzer 2-Product Status 31

Table 17: Coagulyzer 2-Product Description 32

Table 18: Coagulyzer 4-Product Status 32

Table 19: Coagulyzer 4-Product Description 33

Table 20: Fibrinogen Lyophilisat Coagulation Kit-Product Status 33

Table 21: Fibrinogen Lyophilisat Coagulation Kit-Product Description 33

Table 22: Prothrombin Time Coagulation Reagent-Product Status 34

Table 23: Prothrombin Time Coagulation Reagent-Product Description 34

Table 24: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 35

Table 25: AtomoRapid-Coagulation Monitoring-Product Status 35

Table 26: AtomoRapid-Coagulation Monitoring-Product Description 35

Table 27: BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36

Table 28: Portable Diagnostic System-Hemostasis-Product Status 36

Table 29: Portable Diagnostic System-Hemostasis-Product Description 36

Table 30: Braun Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

Table 31: Bio6-Product Status 37

Table 32: Bio6-Product Description 37

Table 33: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

Table 34: Micropoc-CAT-Haemostasis Assay-Product Status 38

Table 35: Micropoc-CAT-Haemostasis Assay-Product Description 38

Table 36: Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview 39

Table 37: Multiple Blood Analytes Test-Product Status 39

Table 38: Multiple Blood Analytes Test-Product Description 39

Table 39: Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Table 40: Calibrated Automated Thrombogram-Thrombin Assay-Product Status 40

Table 41: Calibrated Automated Thrombogram-Thrombin Assay-Product Description 41

Table 42: STA Compact Max-NeoPTimal ISI-Product Status 41

Table 43: STA Compact Max-NeoPTimal ISI-Product Description 41

Table 44: STA Compact Max-Ristocetin Cofactor Assay-Product Status 42

Table 45: STA Compact Max-Ristocetin Cofactor Assay-Product Description 42

Table 46: STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Status 42

Table 47: STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Description 43

Table 48: STA-R Evolution Expert-Automated Ecarin Chromogenic Assay-Product Status 43

Table 49: STA-R Evolution Expert-Automated Ecarin Chromogenic Assay-Product Description 43

Table 50: STA-R Evolution Plus-Automated Ecarin Chromogenic Assay-Product Status 44

Table 51: STA-R Evolution Plus-Automated Ecarin Chromogenic Assay-Product Description 44

Table 52: STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Status 44

Table 53: STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Description 45

Table 54: STA-R Max-NeoPTimal ISI-Product Status 45

Table 55: STA-R Max-NeoPTimal ISI-Product Description 45

Table 56: STA-R Max-Ristocetin Cofactor Assay-Product Status 46

Table 57: STA-R Max-Ristocetin Cofactor Assay-Product Description 46

Table 58: STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Status 46

Table 59: STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Description 46

Table 60: Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Table 61: i15-Coagulation Test-Product Status 47

Table 62: i15-Coagulation Test-Product Description 47

Table 63: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 48

Table 64: Point-Of-Care Test-Coagulation-Product Status 48

Table 65: Point-Of-Care Test-Coagulation-Product Description 48

Table 66: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Table 67: ELITe InGenius-Coagulation Factors Panel-Product Status 49

Table 68: ELITe InGenius-Coagulation Factors Panel-Product Description 49

Table 69: Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview 50

Table 70: ClotSeek-Product Status 50

Table 71: ClotSeek-Product Description 50

Table 72: Gen-Probe Inc Pipeline Products & Ongoing Clinical Trials Overview 51

Table 73: Diagnostic Assay-Coagulation Disorders-Product Status 51

Table 74: Diagnostic Assay-Coagulation Disorders-Product Description 51

Table 75: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 52

Table 76: DG-Chrom PC-Product Status 53

Table 77: DG-Chrom PC-Product Description 53

Table 78: Hemostasis Reagent-DG-APC-Product Status 53

Table 79: Hemostasis Reagent-DG-APC-Product Description 53

Table 80: Hemostasis Reagent-DG-Chrom Hep-Product Status 54

Table 81: Hemostasis Reagent-DG-Chrom Hep-Product Description 54

Table 82: Hemostasis Reagent Kit-DG-APTT Synth G-Fib L Human-Product Status 54

Table 83: Hemostasis Reagent Kit-DG-APTT Synth G-Fib L Human-Product Description 55

Table 84: Hemostasis Reagent Kit-DG-FII-Product Status 55

Table 85: Hemostasis Reagent Kit-DG-FII-Product Description 55

Table 86: Hemostasis Reagent Kit-DG-FIX-Product Status 56

Table 87: Hemostasis Reagent Kit-DG-FIX-Product Description 56

Table 88: Hemostasis Reagent Kit-DG-FV-Product Status 56

Table 89: Hemostasis Reagent Kit-DG-FV-Product Description 57

Table 90: Hemostasis Reagent Kit-DG-FVII-Product Status 57

Table 91: Hemostasis Reagent Kit-DG-FVII-Product Description 57

Table 92: Hemostasis Reagent Kit-DG-FVIII-Product Status 58

Table 93: Hemostasis Reagent Kit-DG-FVIII-Product Description 58

Table 94: Hemostasis Reagent Kit-DG-FX-Product Status 58

Table 95: Hemostasis Reagent Kit-DG-FX-Product Description 59

Table 96: Hemostasis Reagent Kit-DG-FXI-Product Status 59

Table 97: Hemostasis Reagent Kit-DG-FXI-Product Description 59

Table 98: Hemostasis Reagent Kit-DG-FXII-Product Status 60

Table 99: Hemostasis Reagent Kit-DG-FXII-Product Description 60

Table 100: Hemostasis Reagent Kit-DG-Latex D Dimer-Product Status 60

Table 101: Hemostasis Reagent Kit-DG-Latex D Dimer-Product Description 61

Table 102: Hemostasis Reagent Kit-DG-Latex VWF: Gp1b-Product Status 61

Table 103: Hemostasis Reagent Kit-DG-Latex VWF: Gp1b-Product Description 61

Table 104: Hemostasis Reagent Kit-DG-PT RecombiLIQ-Product Status 61

Table 105: Hemostasis Reagent Kit-DG-PT RecombiLIQ-Product Description 62

Table 106: Hemostasis Reagent Kit-DG-TT L Human-Product Status 62

Table 107: Hemostasis Reagent Kit-DG-TT L Human-Product Description 62

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Alere Inc, Afinion PT Test - Capillary Blood; Analyticon Biotechnologies AG, Coagulyzer 1; Analyticon Biotechnologies AG, Coagulyzer 100; Analyticon Biotechnologies AG, Coagulyzer 2; Analyticon Biotechnologies AG, Coagulyzer 4; Analyticon Biotechnologies AG, Fibrinogen Lyophilisat Coagulation Kit; Analyticon Biotechnologies AG, Prothrombin Time Coagulation Reagent; Atomo Diagnostics Pty Limited, AtomoRapid - Coagulation Monitoring; BioMedica USA LLC (Inactive), Portable Diagnostic System - Hemostasis; Braun Biosystems, Inc., Bio6; Carclo Diagnostic Solutions Ltd, Micropoc-CAT - Haemostasis Assay; Cascade Metrix LLC, Multiple Blood Analytes Test; Diagnostica Stago Inc, Calibrated Automated Thrombogram - Thrombin Assay; Diagnostica Stago Inc, STA Compact Max - NeoPTimal ISI; Diagnostica Stago Inc, STA Compact Max - Ristocetin Cofactor Assay; Diagnostica Stago Inc, STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa; Diagnostica Stago Inc, STA-R Evolution Expert - Automated Ecarin Chromogenic Assay; Diagnostica Stago Inc, STA-R Evolution Plus - Automated Ecarin Chromogenic Assay; Diagnostica Stago Inc, STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa; Diagnostica Stago Inc, STA-R Max - NeoPTimal ISI; Diagnostica Stago Inc, STA-R Max - Ristocetin Cofactor Assay; Diagnostica Stago Inc, STA-R Max - Rivaroxaban Calibrators And Controls For Anti-Xa; Edan Instruments Inc, i15 - Coagulation Test; EKF Diagnostics Holdings Plc, Point-Of-Care Test - Coagulation; ELITechGroup Inc, ELITe InGenius - Coagulation Factors Panel; Emosis SAS, ClotSeek; Gen-Probe Inc, Diagnostic Assay - Coagulation Disorders; Grifols SA, DG-Chrom PC; Grifols SA, Hemostasis Reagent - DG-APC; Grifols SA, Hemostasis Reagent - DG-Chrom Hep; Grifols SA, Hemostasis Reagent Kit - DG-APTT Synth G-Fib L Human; Grifols SA, Hemostasis Reagent Kit - DG-FII; Grifols SA, Hemostasis Reagent Kit - DG-FIX; Grifols SA, Hemostasis Reagent Kit - DG-FV; Grifols SA, Hemostasis Reagent Kit - DG-FVII; Grifols SA, Hemostasis Reagent Kit - DG-FVIII; Grifols SA, Hemostasis Reagent Kit - DG-FX; Grifols SA, Hemostasis Reagent Kit - DG-FXI; Grifols SA, Hemostasis Reagent Kit - DG-FXII; Grifols SA, Hemostasis Reagent Kit - DG-Latex D Dimer; Grifols SA, Hemostasis Reagent Kit - DG-Latex VWF: Gp1b; Grifols SA, Hemostasis Reagent Kit - DG-PT RecombiLIQ; Grifols SA, Hemostasis Reagent Kit - DG-TT L Human; Grifols SA, Thrombophilia Reagent Kit - DG-Chrom Anti Xa; Grifols SA, Thrombophilia Reagent Kit - DG-Chrom AT L; Grifols SA, Thrombophilia Reagent Kit - DG-Clot PS; Grifols SA, Thrombophilia Reagent Kit - DG-DRVVT; Grifols SA, Thrombophilia Reagent Kit - DG-DRVVT Confirm; Grifols USA LLC, DG-PT; Hansjorg Wyss Institute for Biologically Inspired Engineering, Hemostasis Monitoring Microfluidic Device; Helena Laboratories Corp, Actalyke Mini II - APTT Test; Helena Laboratories Corp, Actalyke Mini II - LMWH Test; Helena Laboratories Corp, Actalyke Mini II - PT Test; Helena Laboratories Corp, Actalyke XL - APTT Test; Helena Laboratories Corp, Actalyke XL - Heparin Test; Helena Laboratories Corp, Actalyke XL - LMWH Test; Helena Laboratories Corp, Actalyke XL - PT Test; Helena Laboratories Corp, AggRAM - Chromogenic Test; Helena Laboratories Corp, AggRAM - HIT Test; Helena Laboratories Corp, AggRAM - Lumi Test; Helena Laboratories Corp, Cascade Abrazo - Activated Partial Thromboplastin Time (aPTT); Helena Laboratories Corp, Cascade Abrazo - c-ACT; Helena Laboratories Corp, Cascade Abrazo - c-ACT-LR; Helena Laboratories Corp, Cascade Abrazo - Direct Oral Anticoagulants Test; Helena Laboratories Corp, Cascade Abrazo - Direct Thrombin Inhibitors; Helena Laboratories Corp, Cascade Abrazo - Fibrinogen; Helena Laboratories Corp, Cascade Abrazo - Heparin Titration; Helena Laboratories Corp, Cascade Abrazo - LMWH; Helena Laboratories Corp, Cascade Abrazo - Protamine Titration; Helena Laboratories Corp, Cascade Abrazo - PT-C; Helena Laboratories Corp, Cascade Abrazo Analyzer; Helena Laboratories Corp, Cascade M - DRVVT Test; Helena Laboratories Corp, Cascade M-4 - DRVVT Test; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Chronic Liver Disease; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Intensive Care; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Neurosurgery; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Oral Contraception; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Orthopedic Surgery; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Perinatal Care; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Trauma; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer HS-GHA; HemoSonics, LLC, Quantra Hemostasis Analyzer; Instrumentation Laboratory Company, ACL AcuStar - a2GPI Domain I Assay; Instrumentation Laboratory Company, ACL AcuStar - HIT IgG Test; Instrumentation Laboratory Company, ACL AcuStar - HIT Total ab Test; Instrumentation Laboratory Company, ACL AcuStar - VWF: RCo Assay; Instrumentation Laboratory Company, ACL AcuStar - VWF:Ag Assay; Instrumentation Laboratory Company, ACL TOP 300 CTS system - Global Protein C Pathway Test; Instrumentation Laboratory Company, ACL TOP 300 CTS System - HIT Assay; Instrumentation Laboratory Company, ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Activity Assay; Instrumentation Laboratory Company, ACL TOP 350 CTS System - VWF Ristocetin Cofactor Activity Assay; Instrumentation Laboratory Company, ACL TOP 500 CTS System - Global Protein C Pathway Test; Instrumentation Laboratory Company, ACL TOP 500 CTS System - HIT Test; Instrumentation Laboratory Company, ACL TOP 500 CTS System - VWF Ristocetin Cofactor Activity Assay; Instrumentation Laboratory Company, ACL TOP 550 CTS System - VWF Ristocetin Cofactor Activity Assay; Instrumentation Laboratory Company, ACL TOP 700 - HIT Test; Instrumentation Laboratory Company, ACL TOP 700 CTS System - VWF Ristocetin Cofactor Activity Assay; Instrumentation Laboratory Company, ACL TOP 700 System - Global Protein C Pathway Test; Instrumentation Laboratory Company, ACL TOP 750 CTS System - VWF Ristocetin Cofactor Activity Assay; Instrumentation Laboratory Company, Dabigatran Direct Thrombin Inhibitor Assay; Instrumentation Laboratory Company, HemoSIL ACL AcuStar - VWF:CB Assay; Instrumentation Laboratory Company, HemosIL Acustar HIT-Ab (PF4-H) Assay; Instrumentation Laboratory Company, HemosIL Apixaban Testing Assay; Instrumentation Laboratory Company, Rivaroxaban Liquid Anti-Xa Assay; Massachusetts General Hospital, High Throughput Screening Assay - Fibrin-Binding Probes; Nexus Medical, LLC, ProTime InRhythm; Novametics Inc (Inactive), Blood Coagulation Diagnostic Assay; Pakwa Technologies, Platelet ActiSense; PortaScience Inc, PortaPT; Precision Biologics Inc, MNBA Kit - Hemophilia A; Radiometer Medical ApS, AQT90 FLEX - APTT Test; Radiometer Medical ApS, AQT90 FLEX - PT-INR Test; Rappaport Family Institute for Research in the Medical Science, Diagnostic Kit - Hypercoagulation; rHealth, rHEALTH Coagulation Assay; SATT Conectus Alsace SAS, Biomarker Assay - Sepsis; Sekisui Diagnostics LLC, Coapresta 2000 Chromogenic Assay - APL; Sekisui Diagnostics LLC, Coapresta 2000 Chromogenic Assay - Heparin; Sekisui Diagnostics LLC, Coapresta 2000 Chromogenic Assay - PLG; Sekisui Diagnostics LLC, Coapresta 2000 Clotting Time Assay - Factor XII; Sekisui Diagnostics LLC, Coapresta 2000 Clotting Time Assay - PC; Sekisui Diagnostics LLC, Coapresta 2000 Latex Turbidimetry Assay - SF; Siemens Healthcare GmbH, Sysmex CA-1500 - Innovance VWF Activity Assay; Siemens Healthcare GmbH, Sysmex CA-1500 - PT Multicalibrators Assay; Siemens Healthcare GmbH, Sysmex CA-530 - PT Multicalibrators Assay; Siemens Healthcare GmbH, Sysmex CA-560 - Innovance VWF Activity Assay; Siemens Healthcare GmbH, Sysmex CA-560 - PT Multicalibrators Assay; Siemens Healthcare GmbH, Sysmex CA-7000 - Innovance VWF Activity Assay; Siemens Healthcare GmbH, Sysmex CA-7000 - PT Multicalibrators Assay; Siemens Healthcare GmbH, Sysmex CS-2000i System - Multifibren U Assay; Siemens Healthcare GmbH, Sysmex CS-2500 System - Batroxobin Time Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - a2-Antiplasmin Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - Factor II Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - Factor VIII Chromogenic Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - Factor VIII Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - Factor X Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - Factor XI Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - Factor XII Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - Free Protein S Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - Plasminogen Test; Siemens Healthcare GmbH, Sysmex CS-2500 System - Von Willebrand Factor Test; Siemens Healthcare GmbH, Sysmex CS-5100 System - Alpha 2-antiplasmin Assay; Siemens Healthcare GmbH, Sysmex CS-5100 System - Batroxobin Time Assay; Siemens Healthcare GmbH, Sysmex CS-5100 System - Factor XII Assay; Siemens Healthcare GmbH, Sysmex CS-5100 System - Factor II Assay; Siemens Healthcare GmbH, Sysmex CS-5100 System - Factor VIII Chromogenic Assay; Siemens Healthcare GmbH, Sysmex CS-5100 System - Factor X Assay; Siemens Healthcare GmbH, Sysmex CS-5100 System - Factor XI Assay; Siemens Healthcare GmbH, Sysmex CS-5100 System - Free Protein S; Siemens Healthcare GmbH, Sysmex CS-5100 System - TT Assay; Siemens Healthcare GmbH, Sysmex CS-5100 System - Von Willebrand Factor Assay; SonoMedix, Inc., NanoAcoustic Blood Analyzer; SQI Diagnostics Inc, IgXPlex - HIT Assay; Stichting Lygature, Acute Marker Assay; Stichting Lygature, Blood Capacity Assay; Stichting Lygature, Diagnostic Test - Thrombosis; Tarabios, Handheld System - Blood Thinning Therapy; Transfusion &; Transplantation Technologies (Inactive), Aegis - DIC Assay; Universal Biosensors Inc, Diagnostic Assay - Coagulation; Universal Biosensors Inc, Handheld POC Coagulation Testing System - Ambulatory Care; University of Colorado, Thrombelastography Assay; University of Michigan, mHemoRetractoMeter; University of Texas Health Science Center at Houston, MEMS Based Blood Coagulometer; University of Vermont, Diagnostic Assay - Hemophilia


Companies

Alere Inc

Analyticon Biotechnologies AG

Atomo Diagnostics Pty Limited

BioMedica USA LLC

Braun Biosystems, Inc.

Carclo Diagnostic Solutions Ltd

Cascade Metrix LLC

Diagnostica Stago Inc

Edan Instruments Inc

EKF Diagnostics Holdings Plc

ELITechGroup Inc

Emosis SAS

Gen-Probe Inc

Grifols SA

Grifols USA LLC

Hansjorg Wyss Institute for Biologically Inspired Engineering

Helena Laboratories Corp

HemoSonics, LLC

Instrumentation Laboratory

Massachusetts General Hospital

Nexus Medical, LLC

Novametics Inc

Pakwa Technologies

PortaScience Inc

Precision Biologics Inc

Radiometer Medical ApS

Rappaport Family Institute for Research in the Medical Science

rHealth

SATT Conectus Alsace SAS

Sekisui Diagnostics LLC

Siemens Healthcare GmbH

SonoMedix, Inc.

SQI Diagnostics Inc

Stichting Lygature

Tarabios

Transfusion & Transplantation Technologies

Universal Biosensors Inc

University of Colorado

University of Michigan

University of Texas Health Science Center at Houston

University of Vermont